Kurt Karst speaking at Respiratory Drug Delivery Conference

To 505(b)(2) or Not To 505(b)(2)  Jumping the Legal Hurdles for Inhaled Drug Products

When

May 13, 2012

Kurt Karst is speaking on “To 505(b)(2) or Not To 505(b)(2)  Jumping the Legal Hurdles for Inhaled Drug Products” at the Respiratory Drug Delivery conference.

JW Marriott Desert Ridge Resort & Spa

Phoenix, Arizona